Life Sciences Review: VendorViewPoint Listing
The Pre-NDA/BLA Meeting: The Meeting Most Companies Get Wrong
Tom Hallam, President and COO, Facet Life Sciences
Know the Buyer Before the Buyer Knows You
Aaron Mazze, Principal and Founder, Inveniv
Guidance Revision, Recent Survey and PharmaLab Pre-Conference
Dr Markus Funk, Director Operations, CONCEPT HEIDELBERG GmbH
The RNA Opportunity: Why Drug Discovery's Next Chapter Will Be...
Nazli Azimi, Co-Founder and CEO, Therna Biosciences
AI Is Accelerating Drug Discovery. Now It Has to Fix Recruitment
Curtis Hougland, Founder & Philip Storer, Partner, Seen & Heard Health
From Pitfalls to Playbook: Modern Advisory in Life Sciences...
Oded Ben-Joseph, PhD, MBA, Outcome Capital
Accuracy, Access and Assurance: The New Priorities in...
Gary Parish, CEO, HD Barcode LLC, Complete Inspection Systems
What is Abuse Potential Assessment?
Thomas Hudzik, Principal Executive, ALA+ BioPharma Consulting
Semen Analysis Testing: Removing Barriers to Wellness and Male...
Charles Jenkins, Product Director, ReproSource









